Clinical Trial

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

Name: Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer — clinical trial record (NCT06959082)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This will be a multi-center, randomized, open-label, parallel-group study in adult patients with head and neck cancer.

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-06-17

Trial Details

NCT Number	NCT06959082
Lead Sponsor	VSPharmTech Co.,Ltd.
Conditions	Head and Neck Cancer Squamous Cell Carcinoma
Enrollment	30 participants
Start Date	2026-06
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-22